Mavacamten associated with improvement in submaximal exertional tolerance: A secondary analysis of the EXPLORER-HCM randomized trial
1. In the EXPLORER-HCM trial, among 251 included patients, there were significant improvements with mavacamten vs placebo in cardiopulmonary exercise ...